BioSpace News Archive

Quoin Pharmaceuticals Ltd. announces that its open label study evaluating QRX003 as a treatment for Netherton Syndrome has reached 50% enrollment.

With the launch of a new website dedicated to their global clinical trials, Paradigm Biopharmaceuticals Ltd. aims to provide relief to millions of osteoarthritis sufferers worldwide by developing a new injectable drug.

Sarepta Therapeutics, Inc. today provided the following update on the Biologics License Application (BLA) for SRP-9001 (delandistrogene moxeparvovec), which is currently under review for the treatment of ambulant individuals with Duchenne muscular dystrophy (DMD) who have a confirmed mutation of the DMD gene.

Twist Bioscience Corporation today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming investor conferences.

TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, has announced the expansion of its mRNA manufacturing capabilities to serve late-phase drug developers.

GE HealthCare, a leader in precision care innovation, is announcing that its President and CEO Peter Arduini will present at the Jefferies Healthcare Conference in New York City on June 7, 2023 from 10:30 am to 10:55 am ET.

Ajax Therapeutics, Inc. today announced the appointment of Eric S. Fischer, PhD, to the Company’s Scientific Advisory Board (SAB).

Sinaptica Therapeutics, Inc announces the appointment of Ken Mariash Jr. as Chief Executive Officer.

Enveric Biosciences, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application involving its EVM201 Series.

GE HealthCare, a leader in breast cancer care technology and diagnostics, has announced that NCCN Guidelines® for clinicians and patients now recommend the use of FES PET for ER+ positive disease under certain circumstances during the systemic staging workup of patients with recurrent or metastatic breast cancer.